Literature DB >> 9051877

Blood lipid and lipoprotein levels and the risk of cancer of the colon and rectum. A prospective study of 62,173 Norwegian men and women.

M Gaard1, S Tretli, P Urdal.   

Abstract

BACKGROUND: Concern has been raised that a low total serum cholesterol level, although beneficial for cardiovascular diseases, may increase the risk of cancer. This prospective cohort study analyses the hypotheses that a low total serum cholesterol level or its subfractions (serum low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, and triglycerides) increase the risk of cancer of the colon and rectum.
METHODS: Between 1977 and 1983, 62,173 men and women attended a health screening carried out by the Norwegian National Health Screening Service. The screening consisted of a questionnaire, anthropometric measurements, and samples of non-fasting blood drawn for analyses of serum total cholesterol, low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, and triglycerides.
RESULTS: During the 7- to 13-year follow-up, 186 patients were found to have colon cancer and 106 rectal cancer by linkage to the Norwegian Cancer Registry. Among men there were no associations between blood lipid and lipoprotein levels and risk of cancer of the proximal colon, distal colon, or the rectum. Among women there was a formal statistically significant inverse relationship between level of total cholesterol and low-density-lipoprotein cholesterol and risk of distal colon cancer, and a positive trend between total cholesterol level and rectal cancer.
CONCLUSIONS: The statistically significant results among women were interpreted as incidental, and we conclude that blood lipid and lipoprotein levels were not associated with the risk of colon or rectum cancer in men or women in this cohort.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051877     DOI: 10.3109/00365529709000187

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Lipid levels in serum and cancerous tissues of colorectal cancer patients.

Authors:  Xin Zhang; Xian-Wen Zhao; Dong-Bo Liu; Cun-Zhi Han; Li-Li Du; Jie-Xiang Jing; Yan Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer.

Authors:  Ikuko Kato; Susan Land; Adhip P Majumdar; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cancer Epidemiol       Date:  2010-03-21       Impact factor: 2.984

3.  Plasma lipid levels and colorectal adenoma risk.

Authors:  John-Anthony Coppola; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Qi Dai; Reid M Ness; Sergio Fazio; Wei Zheng; Harvey J Murff
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

4.  Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Authors:  Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-09-23       Impact factor: 2.506

5.  Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men.

Authors:  Masafumi Tabuchi; Joji Kitayama; Hirokazu Nagawa
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

6.  Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies.

Authors:  Chen Zhang; Yunjiu Cheng; Dongling Luo; Jinghua Wang; Jianhua Liu; Yujun Luo; Weijie Zhou; Zewei Zhuo; Kehang Guo; Ruijie Zeng; Jun Yang; Weihong Sha; Hao Chen
Journal:  EClinicalMedicine       Date:  2021-03-18

7.  Relationship between serum lipid level and colorectal cancer: a systemic review and meta-analysis.

Authors:  Zhenpeng Yang; Huazhen Tang; Shuai Lu; Xibo Sun; Benqiang Rao
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.